Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dae64c775f32c43199adbb4389c2c9b3 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-368 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-891 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-738 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-671 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-608 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-37 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7008 |
filingDate |
2002-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2008-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_571f5f8adf6514f20c3282466f093b9b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d08941f425f1cd861e684b60d403377e |
publicationDate |
2008-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1543821-B1 |
titleOfInvention |
External preparation |
abstract |
A composition for application to skin comprising (a) an N-retinoyl-D-glucosamine compound wherein the retinoyl group contains at least 0.5% of cis -isomer; and (b) a percutaneous absorption accelerator. |
priorityDate |
2002-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |